Literature DB >> 11274144

Secretory phospholipase A2 mediates cooperative prostaglandin generation by growth factor and cytokine independently of preceding cytosolic phospholipase A2 expression in rat gastric epithelial cells.

S Akiba1, R Hatazawa, K Ono, K Kitatani, M Hayama, T Sato.   

Abstract

Transforming growth factor (TGF)-alpha and interleukin (IL)-1beta are responsible for the healing of gastric lesions through, in part, prostaglandin (PG) generation. We examined the contribution of cytosolic and secretory phospholipase A(2)s (cPLA(2) and sPLA(2)) to the PG generation by rat gastric epithelial cells in response to both stimuli. Stimulation with TGF-alpha for 24 h increased cPLA(2) and cyclooxygenase (COX)-2 markedly, PGE(2) slightly, and type IIA sPLA(2) and COX-1 not at all, whereas IL-1beta increased sPLA(2) only. Both stimuli synergistically increased PGE(2), sPLA(2), and the two COXs but not cPLA(2). The onset of the PGE(2) generation paralleled the sPLA(2) release but was apparently preceded by increases in cPLA(2) and the two COXs. The increase in PGE(2) was impaired by inhibitors for sPLA(2) and COX-2 but not COX-1. cPLA(2) inhibitors suppressed PGE(2) generation by TGF-alpha alone but not augmentation of PGE(2) generation or sPLA(2) release by IL-1beta in combination with TGF-alpha. Furthermore, despite an increase in cPLA(2) including its phosphorylated form (phosphoserine), -induced arachidonic acid liberation was impaired in the TGF-alpha/IL-1beta-stimulated cells, in which p11, a putative cPLA(2) inhibitory molecule, was also increased and co-immunoprecipitated with cPLA(2). These results suggest that synergistic stimulation of sPLA(2) and COX-2 expression by TGF-alpha and IL-1beta results in an increase in PGE(2). Presumably, the preceding cPLA(2) expression is not involved in the PGE(2) generation, because of impairment of its hydrolytic activity in the stimulated cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274144     DOI: 10.1074/jbc.M010201200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  The catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL.

Authors:  Aleksandra A Korotaeva; Elena V Samoilova; Aleksander I Kaminny; Aleksandra A Pirkova; Therese J Resink; Paul Erne; Nina V Prokazova; Vsevolod A Tkachuk; Evgeny I Chazov
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

2.  Intracellular actions of group IIA secreted phospholipase A2 and group IVA cytosolic phospholipase A2 contribute to arachidonic acid release and prostaglandin production in rat gastric mucosal cells and transfected human embryonic kidney cells.

Authors:  Zhanglin Ni; Nicole M Okeley; Brian P Smart; Michael H Gelb
Journal:  J Biol Chem       Date:  2006-04-07       Impact factor: 5.157

3.  Cyclooxygenase 2, pS2, inducible nitric oxide synthase and transforming growth factor alpha in gastric adaptation to stress.

Authors:  Shi-Nan Nie; Hai-Chen Sun; Xue-Hao Wu; Xiao-Ming Qian
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

4.  Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis.

Authors:  Barbara Balestrieri; Victor W Hsu; Huiya Gilbert; Christina C Leslie; Won K Han; Joseph V Bonventre; Jonathan P Arm
Journal:  J Biol Chem       Date:  2006-01-01       Impact factor: 5.157

5.  Cytosolic phospholipase A2-p11 interaction controls arachidonic acid release as a function of epithelial cell confluence.

Authors:  Anne Bailleux; Dominique Wendum; François Audubert; Anne-Marie Jouniaux; Kamen Koumanov; Germain Trugnan; Joëlle Masliah
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

6.  Impact of group IVA cytosolic phospholipase A2 gene polymorphisms on phenotypic features of patients with familial adenomatous polyposis.

Authors:  Junji Umeno; Takayuki Matsumoto; Motohiro Esaki; Yoji Kukita; Tomoko Tahira; Ritsuko Yanaru-Fujisawa; Shotaro Nakamura; Hisatomi Arima; Minako Hirahashi; Kenshi Hayashi; Mitsuo Iida
Journal:  Int J Colorectal Dis       Date:  2009-10-01       Impact factor: 2.571

7.  Secretory PLA2 inhibitor indoxam suppresses LDL modification and associated inflammatory responses in TNFalpha-stimulated human endothelial cells.

Authors:  K Sonoki; M Iwase; N Sasaki; S Ohdo; S Higuchi; Y Takata; M Iida
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

8.  Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model.

Authors:  William R Henderson; Emil Y Chi; James G Bollinger; Ying-tzang Tien; Xin Ye; Luca Castelli; Yuri P Rubtsov; Alan G Singer; Gertrude K S Chiang; Timo Nevalainen; Alexander Y Rudensky; Michael H Gelb
Journal:  J Exp Med       Date:  2007-04-02       Impact factor: 14.307

9.  Piperine inhibits the activities of platelet cytosolic phospholipase A2 and thromboxane A2 synthase without affecting cyclooxygenase-1 activity: different mechanisms of action are involved in the inhibition of platelet aggregation and macrophage inflammatory response.

Authors:  Dong Ju Son; Satoshi Akiba; Jin Tae Hong; Yeo Pyo Yun; Seock Yeon Hwang; Young Hyun Park; Sung Eun Lee
Journal:  Nutrients       Date:  2014-08-22       Impact factor: 5.717

Review 10.  Biology of secretory phospholipase A2.

Authors:  Boris B Boyanovsky; Nancy R Webb
Journal:  Cardiovasc Drugs Ther       Date:  2008-10-14       Impact factor: 3.727

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.